1. Home
  2. MDAI vs PRPO Comparison

MDAI vs PRPO Comparison

Compare MDAI & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MDAI

Spectral AI Inc.

HOLD

Current Price

$1.85

Market Cap

39.6M

Sector

Health Care

ML Signal

HOLD

Logo Precipio Inc.

PRPO

Precipio Inc.

N/A

Current Price

$26.85

Market Cap

44.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
MDAI
PRPO
Founded
2013
N/A
Country
United States
United States
Employees
78
N/A
Industry
Medical/Dental Instruments
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
39.6M
44.4M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
MDAI
PRPO
Price
$1.85
$26.85
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
524.5K
12.5K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
92.15
EPS
N/A
N/A
Revenue
N/A
$24,049,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$23.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
29.77
52 Week Low
$1.13
$5.51
52 Week High
$3.21
$29.80

Technical Indicators

Market Signals
Indicator
MDAI
PRPO
Relative Strength Index (RSI) 62.43 45.44
Support Level $1.78 $22.96
Resistance Level $1.99 $26.16
Average True Range (ATR) 0.12 1.54
MACD 0.01 -0.17
Stochastic Oscillator 75.00 38.84

Price Performance

Historical Comparison
MDAI
PRPO

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Share on Social Networks: